Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126280011 | 12628001 | 1 | I | 201606 | 20160630 | 20160807 | 20160807 | PER | US-TEVA-676134USA | TEVA | 35.03 | YR | M | Y | 0.00000 | 20160808 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126280011 | 12628001 | 1 | PS | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | V01971 | 20622 | INJECTION | |||||||||
| 126280011 | 12628001 | 2 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 126280011 | 12628001 | 3 | C | FISH OIL | FISH OIL | 1 | 0 | ||||||||||||
| 126280011 | 12628001 | 4 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 | ||||||||||||
| 126280011 | 12628001 | 5 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126280011 | 12628001 | 1 | Multiple sclerosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126280011 | 12628001 | Injection site erythema | |
| 126280011 | 12628001 | Injection site mass |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126280011 | 12628001 | 1 | 20160405 | 0 |